(0.08%) 5 521.50 points
(0.13%) 39 895 points
(0.17%) 19 784 points
(-0.06%) $81.58
(0.68%) $2.83
(-0.26%) $2 338.20
(0.08%) $29.55
(0.43%) $1 006.10
(0.05%) $0.932
(-0.07%) $10.53
(0.00%) $0.788
(-0.81%) $87.28
0.12% $ 8.50
Live Chart Being Loaded With Signals
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom...
Stats | |
---|---|
Dzisiejszy wolumen | 5 055 |
Średni wolumen | 23 725 |
Kapitalizacja rynkowa | 27.62M |
EPS | $-2.94 ( Q2 | 2023-08-17 ) |
Następna data zysków | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.245 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0410 (0.48%) |
Wolumen Korelacja
Liminal BioSciences Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Liminal BioSciences Inc Korelacja - Waluta/Towar
Liminal BioSciences Inc Finanse
Annual | 2022 |
Przychody: | $401 000 |
Zysk brutto: | $401 000 (100.00 %) |
EPS: | $-9.32 |
FY | 2022 |
Przychody: | $401 000 |
Zysk brutto: | $401 000 (100.00 %) |
EPS: | $-9.32 |
FY | 2021 |
Przychody: | $643 000 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $0.430 |
FY | 2020 |
Przychody: | $3.32M |
Zysk brutto: | $1.28M (38.71 %) |
EPS: | $-4.83 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Liminal BioSciences Inc
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej